Journal of Cachexia, Sarcopenia and Muscle, 15(3), 455468
Non-Surgical Solutions Non-surgical options for loose skin after weight loss, especially after retatrutide
Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions
Cognitive impairment : problems with concentration, memory impairment, brain fog, and difficulties with decision-making
Key takeaways Wegovy is an FDA-approved prescription drug prescribed for weight loss
Glucagon signals the body to ramp up thermogenesis